(Q48889010)

16 February 2018

title

Hippocampal atrophy as a surrogate of neuronal involvement in Fabry disease (English)

1 reference

16 February 2018

1 reference

3

Edwin Kolodny

1 reference

16 February 2018

author name string

Andreas Fellgiebel

series ordinal

1

1 reference

16 February 2018

Dominik O Wolf

series ordinal

2

1 reference

16 February 2018

Matthias J Müller

series ordinal

4

1 reference

16 February 2018

publication date

20 September 2011

1 reference

16 February 2018

Journal of Inherited Metabolic Disease

published in

1 reference

16 February 2018

volume

35

1 reference

16 February 2018

issue

2

1 reference

16 February 2018

page(s)

363-367

1 reference

16 February 2018

Voxel based analyses of diffusion tensor imaging in Fabry disease.

cites work

1 reference

https://api.crossref.org/works/10.1007%2FS10545-011-9390-9

Voxel-based morphometry–the methods

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10545-011-9390-9

Quantitative analysis of cerebral vasculopathy in patients with Fabry disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10545-011-9390-9

Fabry disease, an under-recognized multisystemic disorder: expert recommendations for diagnosis, management, and enzyme replacement therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10545-011-9390-9

Fabry disease: immunocytochemical characterization of neuronal involvement

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10545-011-9390-9

CNS manifestations of Fabry's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10545-011-9390-9

Diagnostic utility of different MRI and MR angiography measures in Fabry disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10545-011-9390-9

Association of white-matter lesions with brain atrophy markers: the three-city Dijon MRI study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10545-011-9390-9

Nervous system involvement in Fabry's disease: clinicopathological and biochemical correlation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10545-011-9390-9

Cerebrovascular complications of Fabry's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10545-011-9390-9

An autopsy case of Fabry disease with neuropathological investigation of the pathogenesis of associated dementia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10545-011-9390-9

Neuropsychiatric symptoms and brain structural alterations in Fabry disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10545-011-9390-9

The Mainz Severity Score Index: a new instrument for quantifying the Anderson-Fabry disease phenotype, and the response of patients to enzyme replacement therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10545-011-9390-9

Evidence of a smaller left hippocampus and left temporal horn in both patients with first episode schizophrenia and normal control subjects

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10545-011-9390-9

Brain atrophy and cerebral small vessel disease: a prospective follow-up study

21 January 2018

1 reference

12 December 2020

White matter lesion severity in male and female patients with Fabry disease

1 reference

12 December 2020

T1 hyperintensity in the pulvinar: key imaging feature for diagnosis of Fabry disease

1 reference

12 December 2020

Increased signal intensity in the pulvinar on T1-weighted images: a pathognomonic MR imaging sign of Fabry disease.

1 reference

12 December 2020

10.1007/S10545-011-9390-9

Identifiers

DOI

1 reference

16 February 2018

1 reference

16 February 2018